Till now, vaccines were largely associated with inoculation of infants and kids, but now the market for adult vaccines is growing fast. The global vaccine market stood at US$ 11.42 billion in 2006, growing at a rate of 16.52%, it is said to touch US$ 
21.05 billion by 2010, and up to $23.8 billion by 2012. As competition within the industry increases, the vaccine market will resemble the conventional market for pharmaceutical products. Amongst many trends seen within the are that vaccines aimed at anthrax, plague, and smallpox, are being designed to defend against bioterrorist attacks. Also, vaccines to stimulate innate immune responses as well as adaptive are being developed, and more.
21.05 billion by 2010, and up to $23.8 billion by 2012. As competition within the industry increases, the vaccine market will resemble the conventional market for pharmaceutical products. Amongst many trends seen within the are that vaccines aimed at anthrax, plague, and smallpox, are being designed to defend against bioterrorist attacks. Also, vaccines to stimulate innate immune responses as well as adaptive are being developed, and more.
Posts
No comments:
Post a Comment